Clinical significance of the BRAFV600E mutation in Asian patients with colorectal cancer
- 4 June 2018
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 33 (9) , 1173-1181
Abstract
To investigate the clinicopathological features and prognostic significance of the BRAFV600E mutation in Asian patients with colorectal cancer.Keywords
Funding Information
- Taipei Veterans General Hospital (V101E2-005)
- Ministry of Science and Technology, Taiwan (105-2314-B-075 -010 -MY2)
- Department of Health, Taipei City Government (10401-62-031, 10601-62-059)
This publication has 49 references indexed in Scilit:
- BRAFV600E Immunohistochemistry Facilitates Universal Screening of Colorectal Cancers for Lynch SyndromeAmerican Journal of Surgical Pathology, 2013
- Colorectal Cancers from Distinct Ancestral Populations Show Variations in BRAF Mutation FrequencyPLOS ONE, 2013
- Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer PrognosticationJNCI: Journal of the National Cancer Institute, 2013
- A combined oncogenic pathway signature of BRAF , KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment predictionGut, 2012
- BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal ColonAmerican Journal of Surgical Pathology, 2012
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancerBritish Journal of Cancer, 2011
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patientsAnnals of Oncology, 2010
- The Role of the CpG Island Methylator Phenotype in Colorectal Cancer Prognosis Depends on Microsatellite Instability Screening StatusClinical Cancer Research, 2010
- V600E BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathwayProceedings of the National Academy of Sciences, 2009
- Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 CasesCancer Research, 2008